European stocks tumble on doubts about vaccine efficacy against Omicron
European stocks fell more than 1% on Tuesday after vaccine-maker Moderna (NASDAQ:MRNA)’s head cast doubts over the efficacy of COVID-19…
European stocks fell more than 1% on Tuesday after vaccine-maker Moderna (NASDAQ:MRNA)’s head cast doubts over the efficacy of COVID-19…
The dollar was down on Tuesday morning in Asia, just above a one-week low hit during the previous week, as…
The dollar retreated Tuesday as fresh concerns about the impact of the omicron coronavirus variant prompted a rush into the…
The euro zone economy faces risks from a new variant of the coronavirus and rising cases but their impact should…
German import prices rose by 21.7% in October from the same month in the previous year, recording their biggest annual…
Greek private sector bank deposits were almost unchanged in October after rising for eight consecutive months, central bank data showed…
U.S. stocks are seen opening aggressively lower Friday, in holiday-thinned volumes, as the discovery of a new potentially vaccine-resistant Covid…
Bank of England chief economist Huw Pill said the way was clear for the British central bank to follow through…
Britain’s competition regulator said on Friday it had secured improved commitments from Alphabet (NASDAQ:GOOGL)’s Google on changes to user-tracking cookies…
Novacyt (LON:NCYT) shares were trading higher on Friday morning after the company confirmed that its genesig COVID-19 real-time PCR test…